Opportunity Information: Apply for RFA DK 17 027

The National Institutes of Health (NIH) announced a discretionary grant opportunity, RFA-DK-17-027, titled "Incorporating Patient-Reported Outcomes into Clinical Care for Type 1 Diabetes (R01 Clinical Trial Required)." The main purpose of this funding announcement is to support research that tests real-world, healthcare-setting approaches for using patient-reported outcomes (PROs) as practical tools in clinical care for people with type 1 diabetes. The emphasis is on integrating PRO information into routine care in ways that strengthen patient-centered treatment, improve communication and decision-making between patients and clinicians, and ultimately lead to better health and quality-of-life outcomes. Because this is an R01 with a clinical trial required, applicants are expected to propose and carry out a study that prospectively evaluates an intervention or implementation approach, rather than only observational or descriptive work.

At its core, the opportunity is about moving PROs beyond research surveys and into everyday diabetes care workflows. PROs typically capture information that only the patient can directly report, such as diabetes distress, hypoglycemia fear, treatment burden, sleep, pain, mood, or perceived functioning. The FOA’s intent is to fund studies that test how collecting these measures, feeding them back to care teams, and acting on them can improve patient-centered care for type 1 diabetes. In practice, this could include testing clinic-based systems for routine PRO screening, evaluating how PRO results trigger tailored education or behavioral support, studying ways to embed PRO summaries in electronic health records for use during visits, or comparing different strategies for responding to PRO signals (for example, stepped-care pathways, referral protocols, or shared decision-making tools). The focus is explicitly on approaches that can be deployed within healthcare settings, not just on developing new questionnaires.

The funding instrument is an NIH research project grant (R01). The opportunity is categorized under Food and Nutrition and Health, and is associated with CFDA number 93.847. The posted award ceiling is $375,000, indicating the upper bound of the funding amount reflected in the opportunity summary. The original closing date listed for applications was July 10, 2018, and the opportunity record shows a creation date of February 14, 2018. The listing also notes "ExpectedAwards:" but does not provide a number in the source text provided, so the anticipated number of awards is not specified here.

Eligibility is broad across many U.S.-based organization types. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; public housing authorities and Indian housing authorities; Native American tribal organizations other than federally recognized tribal governments; nonprofits with 501(c)(3) status (and nonprofits without 501(c)(3) status), excluding institutions of higher education; for-profit organizations other than small businesses; and small businesses. The announcement also explicitly highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal government agencies, Indian/Native American tribal governments other than federally recognized, and U.S. territories or possessions.

Foreign involvement is restricted. While the text mentions "Non-domestic (non-U.S.) Entities (Foreign Organizations)" in a list of other eligible applicants, it then clearly states that non-domestic (non-U.S.) entities (foreign institutions) are not eligible to apply, that non-domestic components of U.S. organizations are not eligible to apply, and that foreign components (as defined in the NIH Grants Policy Statement) are not allowed. In other words, the work must be led and conducted within eligible U.S.-based applicant structures, without foreign components.

Overall, this FOA is geared toward practical, testable clinical trial projects that demonstrate whether and how integrating patient-reported outcomes into routine type 1 diabetes care improves outcomes that matter to patients and clinicians. Competitive projects under this type of announcement typically align PRO collection with actionable care pathways, demonstrate feasibility within real clinical workflows, and evaluate impacts on both patient-centered outcomes (like distress, functioning, satisfaction, or treatment burden) and diabetes-related clinical outcomes where appropriate.

  • The National Institutes of Health in the food and nutrition, health sector is offering a public funding opportunity titled "Incorporating Patient-Reported Outcomes into Clinical Care for Type 1 Diabetes (R01 Clinical Trial Required)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.847.
  • This funding opportunity was created on 2018-02-14.
  • Applicants must submit their applications by 2018-07-10. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $375,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA DK 17 027

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs)

What is the grant opportunity called?

The opportunity is NIH discretionary grant RFA-DK-17-027, titled "Incorporating Patient-Reported Outcomes into Clinical Care for Type 1 Diabetes (R01 Clinical Trial Required)."

What is the main purpose of this funding opportunity?

The purpose is to support research that tests real-world approaches in healthcare settings for using patient-reported outcomes (PROs) as practical tools in routine clinical care for people with type 1 diabetes.

What does NIH mean by "patient-reported outcomes (PROs)" in this FOA?

PROs are measures capturing information that only the patient can directly report. Examples described include diabetes distress, fear of hypoglycemia, treatment burden, sleep, pain, mood, and perceived functioning.

What is the emphasis of the funded work: developing new PRO questionnaires or implementing PROs in care?

The emphasis is on integrating PRO information into routine care workflows in healthcare settings, not on developing new questionnaires.

What kind of research design is expected?

Because this is an R01 with a clinical trial required, applicants are expected to propose and carry out a prospective study that evaluates an intervention or implementation approach, rather than only observational or descriptive work.

What does "Clinical Trial Required" imply for applicants?

It implies the proposed project must prospectively evaluate an intervention or implementation approach related to incorporating PROs into clinical care. Projects that are purely observational or descriptive would not match the expectation described.

What outcomes is this FOA trying to improve through PRO integration?

The FOA emphasizes strengthening patient-centered treatment, improving communication and decision-making between patients and clinicians, and ultimately improving health and quality-of-life outcomes for people with type 1 diabetes.

What are examples of projects that fit the FOA's intent?

Examples described include testing clinic-based systems for routine PRO screening; evaluating how PRO feedback triggers tailored education or behavioral support; embedding PRO summaries in electronic health records for use during visits; and comparing response strategies such as stepped-care pathways, referral protocols, or shared decision-making tools.

Does the FOA focus on real-world clinical settings?

Yes. The FOA focuses explicitly on approaches that can be deployed within healthcare settings and integrated into everyday care workflows.

What funding mechanism is used for this opportunity?

The funding instrument is an NIH research project grant (R01).

What topic areas or categories is the opportunity associated with?

The opportunity is categorized under Food and Nutrition and Health.

What is the CFDA number associated with this opportunity?

The CFDA number listed is 93.847.

What is the maximum funding amount listed in the opportunity summary?

The posted award ceiling is $375,000, indicating the upper bound of the funding amount reflected in the opportunity summary.

When was the opportunity created and when was the application closing date?

The opportunity record shows a creation date of February 14, 2018, and an original application closing date of July 10, 2018.

How many awards does NIH expect to make under this FOA?

The provided text notes "ExpectedAwards:" but does not include a number, so the anticipated number of awards is not specified in the information provided.

Who is eligible to apply?

Eligibility is broad across many U.S.-based organization types, including: state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; public housing authorities and Indian housing authorities; Native American tribal organizations other than federally recognized tribal governments; nonprofits with 501(c)(3) status and nonprofits without 501(c)(3) status (excluding institutions of higher education); for-profit organizations other than small businesses; and small businesses.

Are minority-serving institutions and community-based organizations eligible?

Yes. The announcement explicitly highlights additional eligible categories such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISI, Hispanic-serving Institutions, HBCUs, TCCUs, faith-based or community-based organizations, and regional organizations.

Are U.S. territories or possessions eligible to apply?

Yes. The announcement explicitly includes U.S. territories or possessions among highlighted eligible applicant categories.

Are federal agencies eligible to apply?

Yes. The announcement highlights eligible federal government agencies as an eligible applicant category.

Can foreign organizations apply?

No. The information provided states that non-domestic (non-U.S.) entities (foreign institutions) are not eligible to apply.

Can a U.S. organization include a non-domestic component or foreign component in the project?

No. The information provided states that non-domestic components of U.S. organizations are not eligible to apply and that foreign components (as defined in the NIH Grants Policy Statement) are not allowed.

Is this FOA focused on type 1 diabetes specifically?

Yes. The title and description focus on incorporating PROs into clinical care for people with type 1 diabetes.

What is the core idea behind this FOA?

The core idea is moving PROs beyond research surveys and into everyday diabetes care workflows by collecting PRO measures, feeding them back to care teams, and using them to guide action in routine clinical care.

What makes a project well-aligned with the goals described in the FOA summary?

Projects described as competitive typically align PRO collection with actionable care pathways, show feasibility within real clinical workflows, and evaluate impacts on patient-centered outcomes (such as distress, functioning, satisfaction, or treatment burden) and, where appropriate, diabetes-related clinical outcomes.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Food and Nutrition, Health

Next opportunity: AHRQ Health Services Research Projects (R01)

Previous opportunity: Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (R43/44 Clinical Trial Not Allowed)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA DK 17 027

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA DK 17 027) also looked into and applied for these:

Funding Opportunity
High-Resolution Exploration of the Human Islet Tissue Environment [HIRN Human Pancreas Analysis Consortium (HPAC)] (U01 Clinical Trial Not Allowed) Apply for RFA DK 17 022

Funding Number: RFA DK 17 022
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $550,000
Discovery of Early Type 1 Diabetes Disease Biomarkers in the Human Pancreas [HIRN Consortium on Beta Cell Death and Survival (CBDS)] (U01 - Clinical Trial Not Allowed) Apply for RFA DK 17 021

Funding Number: RFA DK 17 021
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $500,000
Impact of the Use of Glucose Monitoring and Control Technologies on Health Outcomes and Quality of Life in Older Adults with Type 1 Diabetes (T1D) (R01 Clinical Trial Required) Apply for RFA DK 17 024

Funding Number: RFA DK 17 024
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $500,000
Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R01- Clinical Trial Optional) Apply for RFA DK 17 025

Funding Number: RFA DK 17 025
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $500,000
Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (T1D) (R01 Clinical Trial Optional) Apply for RFA DK 18 004

Funding Number: RFA DK 18 004
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $500,000
High Priority HIV/AIDS Research within the Mission of the NIDDK (R01 Clinical Trial Optional) Apply for PAS 18 698

Funding Number: PAS 18 698
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: Case Dependent
New Directions in Hematology Research (SHINE-II) (R01 Clinical Trial Optional) Apply for PAS 18 730

Funding Number: PAS 18 730
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $200,000
Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21 Clinical Trial Not Allowed) Apply for PA 18 741

Funding Number: PA 18 741
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $200,000
Mechanisms Underlying the Contribution of Type 1 Diabetes Disease-associated Variants (R01 Clinical Trial Not Allowed) Apply for RFA DK 18 005

Funding Number: RFA DK 18 005
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $600,000
Pilot and Feasibility Clinical Research Grants in Urologic Disorders (R21 Clinical Trial Optional) Apply for PAR 18 743

Funding Number: PAR 18 743
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $200,000
Pilot and Feasibility Clinical Research Grants in Kidney Diseases (R21 Clinical Trial Optional) Apply for PAR 18 744

Funding Number: PAR 18 744
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $200,000
Understanding Skeletal Effects of Type 1 Diabetes (R01 Clinical Trial Optional) Apply for RFA DK 18 002

Funding Number: RFA DK 18 002
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $400,000
Regenerative Medicine Innovation Projects (RMIP) (U44 - Clinical Trial Not Allowed) Apply for RFA HL 18 035

Funding Number: RFA HL 18 035
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $225,000
Regenerative Medicine Innovation Projects (RMIP) Investigator-Initiated Studies (Collaborative U01 Clinical Trial Not Allowed) Apply for RFA HL 18 030

Funding Number: RFA HL 18 030
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $250,000
Regenerative Medicine Innovation Projects (RMIP) (UT2 - Clinical Trial Not Allowed) Apply for RFA HL 18 033

Funding Number: RFA HL 18 033
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $225,000
Regenerative Medicine Innovation Projects (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required) Apply for RFA HL 18 031

Funding Number: RFA HL 18 031
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $405,000
New Paradigms in Tissue Communication-from mediators to metabolic function (RC2 Clinical Trials Optional) Apply for PAR 18 886

Funding Number: PAR 18 886
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: Case Dependent
Elucidating the Role of the Autonomic Nervous System in Peripheral Metabolism and Metabolic Disease through the Application of Novel Tools and Methodologies (RC2 Clinical Trial Optional) Apply for PA 18 891

Funding Number: PA 18 891
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: Case Dependent
Elucidating the Role of the Autonomic Nervous System in Peripheral Metabolism and Metabolic Disease through the Application of Novel Tools and Methodologies (RC2 Clinical Trial Optional) Apply for PAR 18 898

Funding Number: PAR 18 898
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: Case Dependent
Human Islet Research Network - Consortium on Human Islet Biomimetics (HIRN-CHIB) (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA DK 18 011

Funding Number: RFA DK 18 011
Agency: National Institutes of Health
Category: Food and Nutrition, Health
Funding Amount: $750,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA DK 17 027", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: